Chad R. Baker’s Dentsply Sirona XRAY Stock Holding History

Chad R. Baker’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-79,820	Closed	-$4.61M	–	63
2016 Q4	$4.61M	Hold	79,820	–	–	2.04%	21
2016 Q3	$4.74M	Hold	79,820	–	–	2.04%	20
2016 Q2	$4.95M	Sell	79,820 -6	-0%	-$369	2.21%	15
2016 Q1	$4.92M	Buy	+79,826	New	+$4.7M	2.23%	17

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Chad R. Baker's XRAY Position: Q1 2017 in Review

Chad R. Baker sold out of Dentsply Sirona (XRAY) in Q1 2017, closing a stake of 79,820 shares — an estimated $4.61M sold.

Chad R. Baker first reported a position in XRAY in Q1 2016 and held it in 4 quarters. The position peaked at $4.95M in Q2 2016. 553 funds tracked by Wall St. Rank hold XRAY as of Q1 2017.

Chad R. Baker reported no remaining Dentsply Sirona position as of Q1 2017 after selling out during the quarter.
Chad R. Baker sold 79,820 Dentsply Sirona shares in Q1 2017, an estimated $4.61M.
Chad R. Baker first reported a position in Dentsply Sirona in Q1 2016 and held it in 4 quarters.
Chad R. Baker's Dentsply Sirona position peaked at $4.95M in Q2 2016.
553 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2017.

Based on Chad R. Baker's 13F filing for Q1 2017, filed 5 May 2017.